Bluebeam has announced Bluebeam Max, a new premium subscription plan designed to bring artificial intelligence into its Revu platform. Launching globally in early 2026, the plan adds automation and ...

Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out diseases or trigger a rush toward enhancement. By Emily Baumgaertner Nunn ...

Bluebeam has launched Bluebeam Max, a new premium subscription that extends its PDF-based collaboration and markup platform, Bluebeam Revu, with workflow automation, intelligent markups and AI-powered ...

Researchers say that they have used a precise genome-editing technique called base editing to alter the genome of human embryos. The announcement has prompted excitement and caution from scientists ...